| Old Articles: <Older 30381-30390 Newer> |
|---|
 |
The Motley Fool
May 28, 2008
Brian Orelli |
A Rough Quarter for Generic-Drug Makers Investors rocked the smaller companies the most.   |
The Motley Fool
May 28, 2008
Brian Lawler |
Discovery's Costly Debt Delay Discovery Labs announces a new financing agreement, but it's an expensive arrangement. |
The Motley Fool
May 28, 2008
Brian Lawler |
A Little-Noticed Drug Rejection The EU temporarily blocks Sanofi and Bristol-Myers' shot at extending a drug's lifespan. |
The Motley Fool
May 28, 2008
Alyce Lomax |
These Booksellers Aren't Best-Sellers These are still difficult times for bookseller stocks like Borders Group and Barnes & Noble. |
The Motley Fool
May 28, 2008
Brian Lawler |
A Strange Novartis MS Drug Story Novartis gets approval for a drug with an interesting history. |
The Motley Fool
May 28, 2008
Chuck Saletta |
You Have More Brains Than Wall Street Read on for an investing lesson that can be learned from the 1939 classic film The Wizard of Oz. |
The Motley Fool
May 28, 2008
Brian Orelli |
A Partnership of Habitual Deal Makers A partnership between these two companies gives Alnylam another $150 million to pad its coffers with and Takeda a call option on an unproven but promising set of drugs. |
The Motley Fool
May 28, 2008
Rick Aristotle Munarriz |
TiVo Does Something Goofy TiVo hooks up with Disney on DVR rentals. |
The Motley Fool
May 28, 2008
Rick Aristotle Munarriz |
XM Could Be a June Bride The drawn-out courtship between XM Satellite Radio and Sirius Satellite Radio -- an engagement that has lasted longer than many Hollywood marriages -- may finally be heading to the altar. |
The Motley Fool
May 28, 2008
Paul Elliott |
The Real China Miracle Investors are looking beyond the skylines of Shanghai and Beijing to The Real China Miracle. Read on to see what it is. |
| <Older 30381-30390 Newer> Return to current articles. |
